NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had imagined — by acting directly on the brain.
A study published in Science Advances by Baylor College of Medicine has uncovered a hidden brain pathway that helps explain how metformin lowers blood sugar, offering fresh insight into a medicine used for over six decades.
For years, metformin was believed to act mainly on the liver and gut. The new research shows it also works through the ventromedial hypothalamus — a small but crucial brain region that controls hunger, energy use and glucose balance.
The drug switches off a protein called Rap1 and activates nerve cells that regulate blood sugar, effectively using the brain’s control system. When this pathway was blocked, metformin stopped working while drugs like insulin remained effective. Even tiny amounts were enough to lower blood sugar.
Lead researcher Makoto Fukuda said the discovery challenges long-held assumptions. Experts said the findings add clarity, not concern.
Select The Times of India as your preferred source on Google SearchAnuja Jaiswal is a Senior Assistant Editor at The Times of India,...
Read MoreAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.
Read Less
Start a Conversation
Post comment